Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2899 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Kowa acquires ProEthic Pharmaceuticals

Effective September 1, 2008, ProEthic will change name to Kowa Pharmaceuticals America and will assume responsibility for all sales and marketing functions currently operating in Montgomery, Alabama. ProEthic’s

InteKrin raises $18.25 million in financing

The financing was led by Skyline Ventures of Palo Alto, California, and managing director David Lowe of Skyline will join InteKrin’s board of directors. Existing major investors Sofinnova

Genoptix appoints new board members

Ms Eastham has been elected to serve as a class I director of Genoptix until the 2011 annual meeting of stockholders and will also serve on the audit

Global Med Technologies acquires eDonor

The transaction consists of $3.5 million in cash and $1.5 million in Global Med common stock. eDonor is a web-based donor relationship management system that integrates recruitment, scheduling,